EN HU

Highly Cited Papers

Faculty of Humanities

1.
Ágoston, C., Balázs, B., Mónus, F., Varga, A.: Age differences and profiles in pro-environmental behavior and eco-emotions.
Int. J. Behav. Dev. "Accepted by Publisher", 1-13, 2024.
Journal metrics:
Q1 Developmental and Educational Psychology
Q1 Developmental Neuroscience
D1 Education
Q1 Life-span and Life-course Studies
Q1 Social Psychology
D1 Social Sciences (miscellaneous)

Faculty of Informatics

1.
Hayrapetyan, A., CMS Collaboration, ATLAS Collaboration: Combination of Measurements of the Top Quark Mass from Data Collected by the ATLAS and CMS Experiments at root{s} = 7 and 8 TeV.
Phys. Rev. Lett. 132 (26), 1-37, (article identifier: 261902), 2024.
2.
Fadhel, M. A., Duhaim, A. M., Saihood, A., Sewify, A., Al-Hamadani, M. N. A., Albahri, A. S., Alzubaidi, L., Gupta, A., Mirjalili, S., Gu, Y.: Comprehensive systematic review of information fusion methods in smart cities and urban environments.
Inf Fusion. 107, 1-34, (article identifier: 102317), 2024.
Journal metrics:
D1 Hardware and Architecture
D1 Information Systems
D1 Signal Processing
D1 Software
3.
Hayrapetyan, A., CMS Collaboration: New Structures in the J/[psi]J/psi Mass Spectrum in Proton-Proton Collisions at root{s} = 13 TeV.
Phys. Rev. Lett. 132 (11), 1-20, (article identifier: 111901), 2024.

Faculty of Medicine

1.
Beghini, A., Sammartino, A. M., Papp, Z., Haehling, S. v., Biegus, J., Ponikowski, P., Adamo, M., Falco, L., Lombardi, C. M., Pagnesi, M., Savarese, G., Metra, M., Tomasoni, D.: 2024 update in heart failure.
ESC Heart Failure. 12 (1), 8-42, 2025.
Journal metrics:
Q1 Cardiology and Cardiovascular Medicine (2024)
2.
Abdul-Rahman, T., Awuah, W. A., Mikhailova, T., Kalmanovich, J., Mehta, A., Cheng Ng, J., Coghlan, M. A., Zivcevska, M., Tedeschi, A. J., de Oliveira, E. C., Kumar, A., Cantu-Herrera, E., Lyndin, M., Sikora, K., Alexiou, A., Bilgrami, A. L., Al-Ghamdi, K. M., Perveen, A., Papadakis, M., Ashraf, G. M.: Antioxidant, anti-inflammatory and epigenetic potential of curcumin in Alzheimer's disease.
Biofactors. 50 (4), 693-708, 2024.
Journal metrics:
Q1 Biochemistry
Q1 Clinical Biochemistry
Q1 Medicine (miscellaneous)
Q1 Molecular Medicine
3.
Szekanecz, Z., Buch, M. H., Charles-Schoeman, C., Galloway, J., Karpouzas, G. A., Kristensen, L. E., Ytterberg, S. R., Hamar, A. B., Fleischmann, R.: Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician.
Nat. Rev. Rheumatol. 20 (2), 101-115, 2024.
Journal metrics:
D1 Rheumatology
4.
GBD 2021 Demographics Collaborators: Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.
Lancet. 403 (10440), 1989-2056, 2024.
5.
GBD 2021 Causes of Death Collaborators: Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
Lancet. 403 (10440), 2100-2132, 2024.
6.
GBD 2021 Fertility and Forecasting Collaborators: Global fertility in 204 countries and territories, 1950-2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.
Lancet. 403 (10440), 2057-2099, 2024.
7.
GBD 2021 Diseases and Injuries Collaborators: Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
Lancet. 403 (10440), 2133-2161, 2024.
8.
Pratz, K. W., Jonas, B. A., Pullarkat, V., Thirman, M. J., Garcia, J. S., Döhner, H., Recher, C., Fiedler, W., Yamamoto, K., Wang, J., Yoon, S. S., Wolach, O., Yeh, S. P., Leber, B., Esteve, J., Mayer, J., Porkka, K., Illés, Á., Lemoli, R. M., Turgut, M., Ku, G., Miller, C., Zhou, Y., Zhang, M., Chyla, B., Potluri, J., DiNardo, C. D.: Long-term follow-up of VIALE-A: Venetoclax and azacitidine in chemotherapy-ineligible untreated acute myeloid leukemia.
Am. J. Hematol. 99 (4), 615-624, 2024.
Journal metrics:
D1 Hematology
9.
Lorusso, D., Xiang, Y., Hasegawa, K., Scambia, G., Leiva, M., Ramos-Elias, P., Acevedo, A., Sukhin, V., Cloven, N., Santana Gomes, A. J. P. d., Contreras Mejía, F., Reiss, A., Ayhan, A., Lee, J. Y., Saevets, V., Zagouri, F., Gilbert, L., Sehouli, J., Tharavichitkul, E., Lindemann, K., Lazzari, R., Chang, C. L., Lampé, R., Zhu, H., Oaknin, A., Christiaens, M., Polterauer, S., Usami, T., Li, K., Yamada, K., Toker, S., Keefe, S. M., Pignata, S., Duska, L. R., ENGOT-cx11/GOG-3047/KEYNOTE-A18 investigators: Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial.
Lancet. 403 (10434), 1341-1350, 2024.
Journal metrics:
D1 Medicine (miscellaneous)
10.
Gaudet, D., Páll, D., Watts, G. F., Nicholls, S. J., Rosenson, R. S., Modesto, K., San Martin, J., Hellawell, J., Ballantyne, C. M.: Plozasiran (ARO-APOC3) for Severe Hypertriglyceridemia: the SHASTA-2 Randomized Clinical Trial.
JAMA Cardiol. 9 (7), 620-630, 2024.
Journal metrics:
D1 Cardiology and Cardiovascular Medicine
11.
Dauw, J., Charaya, K., Lelonek, M., Zegri-Reiriz, I., Nasr, S., Paredes-Paucar, C. P., Borbély, A., Erdal, F., Benkouar, R., Cobo-Marcos, M., Barge-Caballero, G., George, V., Zara, C., Ross, N. T., Barker, D., Lekhakul, A., Frea, S., Ghazi, A. M., Knappe, D., Doghmi, N., Klincheva, M., Fialho, I., Bovolo, V., Findeisen, H., Alhaddad, I. A., Galluzzo, A., Espriella, R. d. l., Tabbalat, R., Miró, Ò., Singh, J. S., Nijst, P., Dupont, M., Martens, P., Mullens, W.: Protocolized Natriuresis-Guided Decongestion Improves Diuretic Response: the Multicenter ENACT-HF Study.
Circ: Heart Failure. 17, 1-10, (article identifier: 011105), 2024.
Journal metrics:
D1 Cardiology and Cardiovascular Medicine
D1 Medicine (miscellaneous)
12.
Erdélyi, A., Pálfi, E., Tűű, L., Nas, K., Szűcs, Z., Török, M., Jakab, A., Várbíró, S.: The Importance of Nutrition in Menopause and Perimenopause: A Review.
Nutrients. 16 (1), 1-21, (article identifier: 27), 2024.
Journal metrics:
D1 Food Science
D1 Nutrition and Dietetics
13.
European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration: Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study.
Lancet. S0140-6736 (23), 1-12, 2023.

Faculty of Science and Technology

1.
Hayrapetyan, A., CMS Collaboration, ATLAS Collaboration: Combination of Measurements of the Top Quark Mass from Data Collected by the ATLAS and CMS Experiments at root{s} = 7 and 8 TeV.
Phys. Rev. Lett. 132 (26), 1-37, (article identifier: 261902), 2024.
2.
Hayrapetyan, A., CMS Collaboration: New Structures in the J/[psi]J/psi Mass Spectrum in Proton-Proton Collisions at root{s} = 13 TeV.
Phys. Rev. Lett. 132 (11), 1-20, (article identifier: 111901), 2024.
3.
Xu, F. W., Wang, K., Liu, T., Tóth, L. V.: The ALMA Survey of Star Formation and Evolution in Massive Protoclusters with Blue Profiles (ASSEMBLE): Core Growth, Cluster Contraction, and Primordial Mass Segregation.
Astrophys. J. Suppl. Ser. 270 (1), 1-31, (article identifier: 9), 2024.
Journal metrics:
D1 Astronomy and Astrophysics
D1 Space and Planetary Science
DEENK University of Debrecen
© 2012 University of Debrecen